Enzon Pharmaceuticals

(OTC) ENZN

Current Price$6.38

Market Cap$92.02M

Since IPO (1987)-65%

5 Year-89%

1 Year-25%

1 Month+6%

Enzon Pharmaceuticals Financials at a Glance

Market Cap

$92.02M

Revenue (TTM)

$0.00

Net Income (TTM)

$3.41M

EPS (TTM)

$-7.46

P/E Ratio

-0.86

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$6.38

Volume

Open

$7.00

Price

$6.38

Volume

Open

$7.00

Previous Close

$6.38

Daily Range

$6.38 - $7.00

52-Week Range

$1.50 - $12.99

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$6.38

Volume

Open

$7.00

Previous Close

$6.38

Daily Range

$6.38 - $7.00

52-Week Range

$1.50 - $12.99

ENZN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Enzon Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

CEO

Thomas Dale Davis, MBA

Website

www.enzon.com

Headquarters

Cranford, NJ 07016, US

ENZN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-8%

Return on Capital

-3%

Return on Assets

-8%

Earnings Yield

-1.16%

Dividend Yield

0.00%

Payout Ratio

-37.40%

Stock Overview

Market Cap

$92.02M

Shares Outstanding

14.43M

Volume

Avg. Volume

1.26K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.36M

EBITDA

$1.36M

Operating Cash Flow

$3.01M

Capital Expenditure

$0.00

Free Cash Flow

$3.01M

Cash & ST Invst.

$42.57M

Total Debt

$0.00

Enzon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$92.02M

N/A

Market Cap/Employee

$92.02M

N/A

Employees

N/A

Net Income

$1.07M

-1387.5%

EBITDA

$318.00K

N/A

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$42.57M

-9.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-7.96%

N/A

Return on Invested Capital

-3.22%

N/A

Free Cash Flow

$682.00K

-401.8%

Operating Cash Flow

$682.00K

-401.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FAMDFFutura Medical plc

FAMDFFutura Medical plc$0.03+200.00%

HLYKHealthLynked Corp.

HLYKHealthLynked Corp.$2.85+8.78%

TDSGFTelo Genomics Corp.

TDSGFTelo Genomics Corp.$0.04+0.00%

LIFDLFTD Partners Inc.

LIFDLFTD Partners Inc.$0.22+0.00%

SRNESorrento Therapeutics, Inc.

SRNESorrento Therapeutics, Inc.$0.00-37.50%

SIGYSigyn Therapeutics, Inc.

SIGYSigyn Therapeutics, Inc.$0.05+11.36%

FNAMEvolutionary Genomics, Inc.

FNAMEvolutionary Genomics, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About ENZN

What is the current price of Enzon Pharmaceuticals?

Enzon Pharmaceuticals is trading at $6.38 per share.

What is the 52-week range for Enzon Pharmaceuticals?

Over the past 52 weeks, Enzon Pharmaceuticals has traded between $1.50 and $12.99.

How much debt does Enzon Pharmaceuticals have?

As of the most recent reporting period, Enzon Pharmaceuticals reported total debt of N/A.

How much cash does Enzon Pharmaceuticals have on hand?

Enzon Pharmaceuticals reported $42.57M in cash and cash equivalents in its most recent financial results.

What is Enzon Pharmaceuticals’s dividend yield?

Enzon Pharmaceuticals does not currently have a dividend yield.

Enzon Pharmaceuticals

Enzon Pharmaceuticals Financials at a Glance

ENZN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Enzon Pharmaceuticals

ENZN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Enzon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ENZN

What is the current price of Enzon Pharmaceuticals?

What is the 52-week range for Enzon Pharmaceuticals?

How much debt does Enzon Pharmaceuticals have?

How much cash does Enzon Pharmaceuticals have on hand?

What is Enzon Pharmaceuticals’s dividend yield?

Premium Investing Services